http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108721564-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-634 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 |
| filingDate | 2017-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108721564-B |
| titleOfInvention | Pharmaceutical composition for treating thrombocytopenia and preparation method and application thereof |
| abstract | The invention provides a pharmaceutical composition for treating thrombocytopenia, which is a preparation prepared from the following raw material medicines in parts by weight: 8-12 parts of curculigo orchioides, 8-12 parts of epimedium, 8-12 parts of lucid ganoderma, 9-15 parts of hairyvein agrimony, 20-30 parts of astragalus membranaceus, 12-18 parts of poria cocos, 12-18 parts of caulis spatholobi and 8-12 parts of radix curcumae. The invention also provides a preparation method and application of the pharmaceutical composition. Aiming at the defects of the existing Chinese patent medicine, on the basis of fully knowing the etiology and pathogenesis of thrombocytopenia caused by radiotherapy and chemotherapy, the medicine adopts a treatment method of warming kidney and strengthening spleen, activating blood and generating blood for the first time, and on the basis of warming and tonifying spleen and kidney, tonifying qi and nourishing blood, the method of activating blood and dissolving stasis is applied to strengthen body resistance and generate blood without leaving blood stasis, and the blood stasis is removed without hurting body resistance, so that the purposes of replenishing qi and blood, eliminating blood stasis and generating new blood are achieved. |
| priorityDate | 2017-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.